Suppr超能文献

血清或血浆中完整人胰岛素的酶免疫测定法。

Enzyme immunoassay for intact human insulin in serum or plasma.

作者信息

Andersen L, Dinesen B, Jørgensen P N, Poulsen F, Røder M E

机构信息

Novo Nordisk A/S, Bagsvaerd, Denmark.

出版信息

Clin Chem. 1993 Apr;39(4):578-82.

PMID:8472350
Abstract

We describe an enzyme-linked two-site immunoassay for quantitation of intact insulin in human serum and plasma. The method uses two murine monoclonal antibodies that bind to two different epitopes on the insulin molecule. The immunoassay is specific. Human proinsulin is not bound by the antibodies, and the binding of partially processed proinsulin intermediates is believed to be of minor clinical importance. The relative response of human, bovine, and porcine insulin is 1, 1, and 3, respectively. The assay is sensitive (detection limit 5 pmol/L), accurate (101% recovery with 50 pmol/L insulin added to samples, 95% with 100 pmol/L, and 89% with 300 pmol/L), and fast (results within 3 h), and has a high analytical capacity (done in microtiter plates). The working assay range selected is 5-600 pmol/L, corresponding to a clinically useful range. Because of its specificity, this two-site immunoassay gives results that are lower than those obtained by using a competitive radioimmunoassay, both in normal individuals and in non-insulin-dependent diabetics.

摘要

我们描述了一种用于定量人血清和血浆中完整胰岛素的酶联双位点免疫测定法。该方法使用两种鼠单克隆抗体,它们与胰岛素分子上的两个不同表位结合。该免疫测定法具有特异性。人胰岛素原不与抗体结合,部分加工的胰岛素原中间体的结合被认为在临床上不太重要。人胰岛素、牛胰岛素和猪胰岛素的相对反应分别为1、1和3。该测定法灵敏(检测限为5 pmol/L)、准确(向样品中添加50 pmol/L胰岛素时回收率为101%,添加100 pmol/L时为95%,添加300 pmol/L时为89%)且快速(3小时内出结果),并且具有高分析能力(在微量滴定板中进行)。所选的有效测定范围为5 - 600 pmol/L,对应于临床有用范围。由于其特异性,这种双位点免疫测定法在正常个体和非胰岛素依赖型糖尿病患者中给出的结果均低于使用竞争性放射免疫测定法所获得的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验